Metabolite Profiling and Network Pharmacology of Persimmon Vinegar (Diospyros kaki) Compounds, with in silico Validation for Non-Small Cell Lung Cancer Therapy

Key Points

• This research aims to evaluate the potential of persimmon vinegar compounds for developing treatments for non-small cell lung cancer.
• Conducted metabolite profiling of persimmon vinegar compounds.
• Applied network pharmacology techniques to identify therapeutic leads.
• Performed in silico validation to assess the efficacy of compounds.
• Identified specific compounds in persimmon vinegar with potential anti-cancer effects.
• Provided preliminary evidence that supports the exploration of these compounds in NSCLC therapy.